Howe & Rusling’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25
Closed -$1K 1186
2022
Q2
$1K Sell
25
-15
-38% -$637 ﹤0.01% 1003
2022
Q1
$3K Sell
40
-150
-79% -$10.8K ﹤0.01% 808
2021
Q4
$17K Buy
190
+100
+111% +$12K ﹤0.01% 457
2021
Q3
$11K Hold
90
﹤0.01% 501
2021
Q2
$15K Hold
90
﹤0.01% 444
2021
Q1
$16K Hold
90
﹤0.01% 436
2020
Q4
$18K Sell
90
-60
-40% -$12.2K ﹤0.01% 409
2020
Q3
$33K Buy
150
+50
+50% +$10.6K 0.01% 306
2020
Q2
$19K Buy
100
+17
+20% +$2.98K ﹤0.01% 357
2020
Q1
$13K Buy
+83
New +$9.66K ﹤0.01% 397
2018
Q4
Sell
-30
Closed -$3K 892
2018
Q3
$3K Hold
30
﹤0.01% 682
2018
Q2
$2K Hold
30
﹤0.01% 691
2018
Q1
$1K Buy
+30
New +$1.13K ﹤0.01% 881
2016
Q3
Sell
-33
Closed -$1K 1118
2016
Q2
$1K Hold
33
﹤0.01% 921
2016
Q1
$0 Hold
33
﹤0.01% 1057
2015
Q4
$1K Hold
33
﹤0.01% 940
2015
Q3
$1K Buy
+33
New +$891 ﹤0.01% 956

Other funds holding TDOC

Howe & Rusling's TDOC Position: Q3 2022 in Review

Howe & Rusling sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 25 shares — an estimated $1K sold.

Howe & Rusling first reported a position in TDOC in Q3 2015 and held it in 17 quarters. The position peaked at $33K in Q3 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Howe & Rusling reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Howe & Rusling sold 25 Teladoc Health shares in Q3 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Teladoc Health in Q3 2015 and held it in 17 quarters.
  • Howe & Rusling's Teladoc Health position peaked at $33K in Q3 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.